Rhodium complex [RhLI2]I: a novel anticancer agent inducing tumor inhibition and apoptosis

Rhodium complex [RhLI2]I: a novel anticancer agent inducing tumor inhibition and apoptosis

Abstract Numerous chemotherapeutic agents are currently employed in cancer treatment, but many are associated with significant side effects. This study aims to identify a novel anticancer drug that minimizes or eliminates these adverse effects. The anticancer activity of the Rhodium (III) complex ci...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Matakabbir Hossain, Kazi Soha, Arifur Rahman, Abdul Auwal, Tasfik Ul Haque Pronoy, K. M. Rashel, M. Nurujjaman, Habibur Rahman, Tapashi G. Roy, Jahan Ara Khanam, Farhadul Islam
Format: Article
Language:English
Published: Springer 2024-12-01
Series:Discover Oncology
Subjects:
Antineoplastic activity
Chemotherapy
Cytotoxic activity
Apoptosis
EAC cells
Online Access:https://doi.org/10.1007/s12672-024-01632-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-024-01632-7

Similar Items